Walgreens $350M Opioid Settlement

Walgreens has agreed to pay up to $350 million in a settlement with the United States — United States Department of Justice, resolving allegations that it illegally filled millions of opioid and other controlled substance prescriptions between 2012 and 2023. The United States — United States Department of Justice accused Walgreens of knowingly dispensing excessive and early opioid prescriptions, as well as dangerous drug combinations, despite clear red flags. Furthermore, Walgreens allegedly pressured its pharmacists to fill prescriptions quickly and sought payment for invalid prescriptions through federal healthcare programs like United States — Medicare, United States — Medicaid, and United States — Tricare, violating the False Claims Act. Walgreens denies liability but agreed to the settlement to close all opioid-related litigation with federal, state, and local governments. As part of the agreement, Walgreens will pay at least $300 million, with an additional $50 million due if the company is sold or merged before 2032. Walgreens has also committed to improving compliance with controlled substance dispensing rules through agreements with the United States — Drug Enforcement Administration and the United States — United States Department of Health and Human Services. This settlement follows a period of instability for Walgreens, including store closures, and is part of a broader trend of over $50 billion in opioid-related settlements across the pharmaceutical industry.